CME in Minutes: Education in Primary Care
By Answers in CME
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Answers in CME
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 147
Description
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Primary Care by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for the busy primary care providers to cover the diagnosis, treatment, follow-up, and clinical management of various disease states. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.
| Episode | Date |
|---|---|
|
The Next Era of CKD Management in T1D: Evolving Care Strategies to Improve Patient Outcomes
|
Apr 01, 2026 |
|
Taking the Long View on DME Management: Practical Approaches With Long-Acting Anti-VEGF Agents
|
Mar 31, 2026 |
|
From Screening to Specialized Care: Navigating Key Questions in Alpha-1 Antitrypsin Deficiency–Associated Liver Disease
|
Mar 31, 2026 |
|
When Form Maximizes Function: Examining the Role of Subcutaneous Immune Checkpoint Inhibitors in Oncology Practice
|
Mar 24, 2026 |
|
Bridging Evidence and Practice: Updates on HER2-Targeted ADCs for Gastric/GEJ Adenocarcinoma
|
Mar 18, 2026 |
|
Managing Cholestatic Pruritus: Changing Lives With IBAT Inhibitors
|
Mar 18, 2026 |
|
Precision Use of Biologic Therapies in Eosinophilic Lung Disease: Case-Based Strategies to Optimize Treatment Selection and Reduce Steroid Burden
|
Mar 13, 2026 |
|
Vasomotor Symptoms Due to Breast Cancer Treatment: The Emergence of Neurokinin Receptor Antagonists
|
Mar 06, 2026 |
|
HoFH in Focus: Practical Strategies for Early Detection and Lifelong Management
|
Mar 05, 2026 |
|
Managing Obesity as a Chronic Condition: The Role of Incretin-Based Therapies in Personalized Care
|
Mar 02, 2026 |
|
Rethinking HER2 Status: Practical Testing Considerations for HER2-Low and -Ultralow Advanced Breast Cancer
|
Feb 19, 2026 |
|
The Psoriatic Disease Playbook: Advancing Care With Novel Oral Therapies in the Evolving PsA Landscape
|
Feb 18, 2026 |
|
A Shared Vision on DME Management: Improving Outcomes With Long-Acting Anti-VEGF Agents
|
Feb 12, 2026 |
|
Breaking Old Habits in Lung Cancer Detection: Expanding Screening Efforts Among At-Risk Populations
|
Feb 10, 2026 |
|
ADC-elerating Progress: Targeting TROP2 in Triple-Negative Breast Cancer to Improve Front-Line Care
|
Feb 03, 2026 |
|
Rapid Roundup 2025: Hot Topics in Myelodysplastic Syndromes and Myelofibrosis
|
Jan 19, 2026 |
|
Advancing Holistic First-Line Care in Advanced Urothelial Carcinoma: Guideline-Based Strategies and Best Practices in Adverse Event Management
|
Jan 13, 2026 |
|
Tina Q. Tan, MD - Infant RSV Protection: Guiding Families Through Immunization Decisions in Clinical Practice
|
Dec 30, 2025 |
|
Karen McAssey, BA, MD, M.Ed, FRCPC - Frail Bones, Strong Impact: Mending Gaps in Hypophosphatasia Recognition Across Canada
|
Dec 24, 2025 |
|
David R. Staskin, MD - Beyond Benign Prostatic Hyperplasia: Unmasking and Addressing Overactive Bladder in Men
|
Dec 23, 2025 |
|
Sherry Rohekar, BSc., MD, FRCPC, MSc - Targeting the IL-17 Pathway in PsA and axSpA: Precision Strategies for Patient-Centered Care
|
Dec 17, 2025 |
|
Jacob Sands, MD / Benjamin Levy, MD, FASCO - What’s Now and What’s Next for ADCs in NSCLC? Integrating HER2- and TROP2-Targeted Therapies Into the Evolving Treatment Landscape
|
Dec 15, 2025 |
|
Taofeek K. Owonikoko, MD, PhD, MS / Ticiana Leal, MD - New Frontiers in Small Cell Lung Cancer: Getting Ready for the Emergence of B7-H3–Directed ADCs
|
Dec 12, 2025 |
|
Nicola Hanania, MD, MS / Surya P. Bhatt, MD, MSPH - Demystifying the Evidence for Biologics in COPD: Strategies for Optimized, Patient-Centered Management
|
Dec 11, 2025 |
|
Sheilagh M. Maguiness, MD, FAAP / Elizabeth Vainder, MD, FAAP - Escalating Atopic Dermatitis Treatment in Pediatric Patients With Confidence: What Do the Guidelines Tell Us?
|
Dec 10, 2025 |
|
Tina Bhutani, MD, MAS, FAAD / Robin K. Dore, MD - The Dermatology-Rheumatology Psoriatic Playbook: Advancing Care With Novel Oral Therapies in the Evolving PsA Landscape
|
Dec 09, 2025 |
|
Stella Lee, MD / Kathleen Buchheit, MD - Striving for Patient Satisfaction in the Present and Future: Personalizing Treatment in an Evolving Paradigm
|
Dec 08, 2025 |
|
Charu Aggarwal, MD, MPH / Benjamin Levy, MD, FASCO - Rapid Roundup in NSCLC: Keeping Up with ADC Therapies Driving Precision Lung Cancer Care
|
Dec 05, 2025 |
|
April W. Armstrong, MD, MPH / Linda Stein Gold, MD / Clive M. Liu, MD - Personalizing Psoriasis Care Across the Map: Navigating Regional Barriers to Integrating Oral Small Molecule Treatment for Moderate to Severe Disease
|
Dec 03, 2025 |
|
Michael Postow, MD - Enhancing First-Line Treatment Selection in Advanced Melanoma: A Patient-Centered Approach
|
Dec 02, 2025 |
|
Mark Awad, MD, PhD / Carl M. Gay, MD, PhD - Breaking News in Small-Cell Lung Cancer: Expert Insights on B7-H3–Directed Antibody–Drug Conjugates From Recent Congresses
|
Dec 01, 2025 |
|
Wells A. Messersmith, MD - Illustrating the Journey to Improved Outcomes for MSI-H/dMMR Metastatic CRC: Bringing Immunotherapy-Based Regimens to the Forefront
|
Nov 28, 2025 |
|
Stella Lee, MD / Joseph K. Han, MD, FARS, FAAAAI - Spotlight on Emerging Biologics: Interpreting the Latest Efficacy and Safety Signals
|
Nov 27, 2025 |
|
Caron Jacobson, MD - Where Do Antibody–Drug Conjugates Fit in Relapsed/Refractory Diffuse Large B-Cell Lymphoma? Addressing Community Questions and Real-World Approaches to Selecting and Sequencing Novel Therapies
|
Nov 25, 2025 |
|
Luis Paz-Ares, MD, PhD / Lauren Averett Byers, MD - Shaping the Future of SCLC Treatment: Advancing Care Through Innovative Approaches
|
Nov 24, 2025 |
|
Seenu M. Hariprasad, MD - A Closer Look at Emerging Anti-VEGF Therapies in Retinal Vein Occlusion Management: Practical Guidance for Specialists
|
Nov 21, 2025 |
|
Doreen Addrizzo-Harris, MD - Relieving the Weight of Non-Cystic Fibrosis Bronchiectasis: Updated Strategies for an Evolving Landscape
|
Nov 20, 2025 |
|
Terry Faleye, MPAS, PA-C / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing Care
|
Nov 19, 2025 |
|
Arielle Elkrief, MD - Navigating Neoadjuvant, Adjuvant, and Perioperative Immunotherapy in Resectable High-Risk Melanoma: Tailoring Care for Optimal Outcomes
|
Nov 18, 2025 |
|
Stella Lee, MD / Kathleen Buchheit, MD - Advances in CRSwNP: Rethinking Biologics and Inflammation at the Source
|
Nov 18, 2025 |
|
Manjot K. Gill, MD, MS, Steven Ferrucci, OD, FAAO - Driving Diagnosis and Navigating the Role of Anti-VEGF Therapies in Managing Retinal Vein Occlusion
|
Nov 13, 2025 |
|
Linda Stein Gold, MD / April W. Armstrong, MD, MPH / Erin Boh, MD, PhD - Personalizing Psoriasis Care Across the Map: Navigating Regional Barriers to Integrating Oral Small Molecule Treatment for Moderate to Severe Disease
|
Nov 07, 2025 |
|
Asim V. Farooq, MD, Erica L. Mayer, MD, MPH - Ocular Safety in Breast Cancer Care: What Eye Clinicians Need to Know About Novel Oral Endocrine Therapies
|
Nov 06, 2025 |
|
Edward B. Garon, MD, MS - A Case of Best Practices: Optimizing First-Line Chemoimmunotherapy for Advanced Squamous NSCLC
|
Nov 03, 2025 |
|
Yasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD
|
Oct 31, 2025 |
|
Luis Paz-Ares, MD, PhD / Kristin Higgins, MD - Creating a Roadmap to Optimize Care for Patients With LS-SCLC: Integrating the Evidence Into Practical Care
|
Oct 30, 2025 |
|
Charles L. Daley, MD / David E. Griffith, MD - Staying on Track with MAC Lung Disease Care: From Accurate Diagnosis to Evolving Management Strategies
|
Oct 28, 2025 |
|
MeiLan Han, MD, MS / Eddie Needham, MD, FAAFP / Valerie Chang - COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control
|
Oct 17, 2025 |
|
Jerry P. Abraham, MD MPH CMQ / Chuck Vega, MD- Primary Care Immunization Showdown: What Would You Do in These Complex Vaccine Scenarios?
|
Oct 15, 2025 |
|
Andrew M. Brunner, MD - FLT3 Inhibitors in Action: Clinical Case Challenges in Newly Diagnosed AML
|
Oct 03, 2025 |
|
Lisa Larkin, MD, FACP, MSCP, IF - Advancing Menopause Management: Integrating Neurokinin-Targeted Therapies for Vasomotor Symptoms
|
Oct 01, 2025 |
|
Alice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes
|
Sep 30, 2025 |
|
Kathleen Moore, MD, MS, FASCO, Debra Richardson, MD - Current and Future Treatment of Platinum-Resistant Ovarian Cancer With ADCs: Implications of Targeting CDH6
|
Sep 30, 2025 |
|
Ramez N. Eskander, MD - Selecting the Optimal Regimen for Advanced Endometrial Cancer: A Case-Based, Multidisciplinary Approach
|
Sep 30, 2025 |
|
Ticiana Leal, MD / Neal Ready, MD, PhD - From Cases to Care: Personalizing First-Line Immunotherapy in Advanced NSCLC Through a Patient-Centered Approach
|
Sep 24, 2025 |
|
Vlad Ratziu, MD, PhD - Bridging Disciplines to Advance Care in MASH: Exploring GLP-1 RAs for Obesity-Related Liver Disease
|
Sep 24, 2025 |
|
Christine Franzese, MD / Eileen Wang, MD, MPH - From Case to Clinic: Personalizing the Use of Biologics in CRSwNP Care Plans
|
Sep 22, 2025 |
|
Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
|
Sep 10, 2025 |
|
Tina Q. Tan, MD / Litjen (L.J) Tan, MS, PhD - Empowering Patients, Strengthening Immunity: Strategies to Increase Influenza Vaccination Across All Age Groups
|
Sep 09, 2025 |
|
Priya Vakharia, MD - The Long View in Neovascular Age-Related Macular Degeneration: Practical Insights on Long-Acting Anti-VEGF Treatment
|
Sep 03, 2025 |
|
Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction
|
Sep 01, 2025 |
|
Jesus Berdeja, MD - Chartering New Frontiers in Myeloma Care: What Role May Novel CELMoDs Play in Early-Relapse Therapy?
|
Aug 18, 2025 |
|
April W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Next-Generation Treatments for Moderate-to-Severe Plaque Psoriasis: What's New in TYK2
|
Aug 04, 2025 |
|
Daniel Petrylak, MD - Answering Key Questions About Biomarkers in Urothelial Cancer: Guidance for Improving Implementation
|
Jul 31, 2025 |
|
Fernando Jose Martinez, MD, MS, Justin Oldham, MD, MS - Advancing Patient-Centered ILD Care: Post-Congress Insights on Antifibrotics, Treatment Innovations, and Multidisciplinary Approaches
|
Jul 29, 2025 |
|
Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World
|
Jul 28, 2025 |
|
John Marshall, MD - Re-Invigorating the Later-Line Treatment of Metastatic Colorectal Cancer: Practical Strategies to Optimize the Use of Tyrosine Kinase Inhibitors
|
Jul 18, 2025 |
|
Neil D. Gross, MD, FACS - Evolving the Multi-Modal Approach for Resectable Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Assessment of Current and Emerging Immunotherapeutic Strategies
|
Jul 11, 2025 |
|
Hussein Tawbi, MD, PhD - Evolving Melanoma Care: The Clinical Impact of Anti-LAG-3/PD-1 Combinations
|
Jul 07, 2025 |
|
Evan S. Dellon, MD, MPH - Stepping Up the Management of Eosinophilic Esophagitis: Answering Key Questions on Diagnosis and Use of Pharmacotherapies
|
Jul 04, 2025 |
|
Thomas Powles, MBBS, MRCP, MD / Jonathan E. Rosenberg, MD - Advancing Urothelial Carcinoma Care With Multidisciplinary Strategies for Clinical Management
|
Jul 03, 2025 |
|
Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors
|
Jul 01, 2025 |
|
James F. Howard Jr., MD - C5 Inhibitors for the Treatment of Generalized Myasthenia Gravis: From Clinical Data to Patient-Centered Strategies
|
Jun 26, 2025 |
|
Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice
|
Jun 24, 2025 |
|
Venkataraman Raman Muthusamy, MD, MAS - A Window of Opportunity: Identifying the Risk of Esophageal Adenocarcinoma With Prognostic Testing
|
Jun 23, 2025 |
|
Nicholas J. Silvestri, MD - Transforming Outcomes for Patients With gMG Through Enhanced Disease Control: A Focus on FcRn Antagonists
|
Jun 12, 2025 |
|
Aditya Bardia, MD / Sara Hurvitz, MD - Making a World of Difference for Patients With HER2-Low and -Ultralow Advanced Breast Cancer: Practical Strategies to Integrate Antibody-Drug Conjugates in Special Populations
|
Apr 16, 2025 |
|
Elizabeth A. Thiele, MD, PhD - Enhancing Diagnosis and Long-Term Care of Patients With Lennox-Gastaut Syndrome: A Case-Based Approach to Optimizing Treatment Strategies
|
Apr 14, 2025 |
|
Komal Jhaveri, MD, FACP - Opportunities to Personalize Care: Making the Case for TROP2-Directed ADCs in HR+, HER2- Metastatic Breast Cancer
|
Apr 10, 2025 |
|
Aditya Bardia, MD / Sara Hurvitz, MD - Realizing the Potential of Antibody-Drug Conjugates in HER2-Low and -Ultralow Advanced Breast Cancer: Evolving Strategies to Individualize Care
|
Apr 10, 2025 |
|
David E. Griffith, MD - Guiding Principles in the Management of Refractory Mycobacterium Avium Complex (MAC) Pulmonary Disease: Casing the Evidence to Inform Practical Care
|
Apr 07, 2025 |
|
Aditya Bardia, MD / Marilyn M. Bui, MD, PhD - Bringing HER2 Low and Ultralow to Light: How to Define and Detect HER2 Status in Advanced Breast Cancer
|
Apr 04, 2025 |
|
Nathan Falk, MD, MBA, FAAFP - Making Sense of Type 2 Inflammation Crosstalk in Chronic Diseases: Perspectives on Improving Emergency and Primary Care Collaboration
|
Apr 02, 2025 |
|
Thomas Martin, MD - Focusing on the Frontline: The Impact of Anti-CD38-Based Quadruplet Regimens for Transplant-Ineligible, Newly-Diagnosed Myeloma
|
Mar 07, 2025 |
|
James E. Galvin, MD, MPH - Voyage Through AD: From Early Detection to Collaborative Care
|
Feb 17, 2025 |
|
Paul Gissen, MD, PhD - A Journey Through Metachromatic Leukodystrophy: From Diagnosis to Clinical Care
|
Feb 05, 2025 |
|
Arvind Dasari, MD - Leveling Up Care in the Later-Line Treatment of Metastatic Colorectal Cancer: Bringing Quality of Life to the Forefront
|
Jan 31, 2025 |
|
Joshua Richter, MD, FACP - Enhancing Outcomes in Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Harnessing Bispecific Antibodies in Community Care
|
Jan 08, 2025 |
|
Jai Radhakrishnan, MD, MS - IgA Nephropathy in Focus: Novel Treatment Strategies for Nephrologists and PCPs
|
Jan 03, 2025 |
|
Scott MacDiarmid, MD - Streamlining Patient Flow: A Clinician’s Guide to Optimizing the Use of Beta-3 Adrenergic Agonists for Overactive Bladder Management
|
Jan 02, 2025 |
|
Arzu Yorgancioglu, MD - A Global Approach to Asthma Management: Examining Biologics
|
Jan 02, 2025 |
|
Claus Bachert, MD, PhD / Cecelia Damask, DO - Managing CRSwNP With Biologic Therapies: A Global Dialogue
|
Dec 20, 2024 |
|
Sunandana Chandra, MD, MS - Practical Guidance on Managing Adverse Events Associated With Immunotherapy Regimens for Nonmelanoma Skin Cancers
|
Dec 17, 2024 |
|
Alexander I. Spira, MD, PhD, FACP - Biomarkers at the Forefront: The Crucial Role of Testing Across Solid Tumor Types
|
Dec 13, 2024 |
|
David Harpole, MD / Alfredo Addeo, MD - The Possibilities of Perioperative: Assessing the Use of Perioperative Immunotherapy for Resectable NSCLC
|
Dec 12, 2024 |
|
Megan Huchko, MD, MPH - Isn't HPV Vaccination Only for Pre-Teens? Answering the Why and How of Adult Vaccination
|
Dec 06, 2024 |
|
Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Advancing Care in EGFR-Mutated NSCLC: Unveiling New Horizons With ADCs
|
Dec 02, 2024 |
|
Erin Barrett (Wei), MD - Focusing on the Patient to Enhance Therapeutic Care: Advancing Early Diagnosis and Management of Bullous Pemphigoid
|
Nov 29, 2024 |
|
Csaba P. Kovesdy, MD - Integrating Nonsteroidal MRAs in Practice: A Guideline-Driven Approach to the Management of CKD and T2D
|
Nov 29, 2024 |
|
Shawn Kwatra, MD - Itching to Reduce the Burden of Prurigo Nodularis: The Latest Evidence and Strategies for Optimizing Biologic Therapy
|
Nov 29, 2024 |
|
David S. Boyer, MD / Irving Posalski, MD - PCP-Specialists Share a Lens to Magnify Outcomes With VEGF-Targeting Agents for DME
|
Nov 26, 2024 |
|
David Harpole, MD / Neel Chudgar, MD - The Practicalities of Perioperative Immunotherapy for Resectable NSCLC
|
Nov 26, 2024 |
|
René S. Kahn, MD, PhD - Elevating the Patient Voice in Bipolar I Disorder Management: A Collaborative Approach to Shared Decision-Making
|
Nov 26, 2024 |
|
David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC
|
Nov 20, 2024 |
|
Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Leveraging Precise Targets to Elevate Outcomes: NSCLC Treatment Strategies for HER2-Directed ADCs
|
Nov 15, 2024 |
|
Jia Ruan, MD, PhD - Clinical Case Challenges in Frontline PTCL: Navigating the Landscape of CD30-Positive PTCL Treatment
|
Nov 15, 2024 |
|
Evan S. Dellon, MD, MPH - In Case of Emergency: Ensuring Timely Recognition and Intervention in Patients With Eosinophilic Esophagitis
|
Nov 06, 2024 |
|
Christoph U. Correll, MD - Transforming the Treatment of Schizophrenia: Moving Beyond Anti-Dopaminergic Antipsychotics to Muscarinic Receptor Agonists
|
Nov 06, 2024 |
|
Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
|
Nov 06, 2024 |
|
Jacob Sands, MD / Raffaele Califano, MD - Novel ADC Targets in Advanced NSCLC: Examining Emerging Strategies for TROP2-Directed ADCs
|
Oct 30, 2024 |
|
Juliana M. Kling, MD, MPH - Turning Down the Heat: Exploring Newly Approved and Emerging Nonhormonal Therapies for Menopause-Associated VMS
|
Oct 07, 2024 |
|
Christoph U. Correll, MD - Pathways to Hope: Emerging Therapies in Alzheimer’s Disease Psychosis
|
Sep 27, 2024 |
|
Stephanie A. Christenson, MD, MAS - Targeting Eosinophils for Fewer Exacerbations: The Future of Biologic Treatments in COPD Management
|
Sep 20, 2024 |
|
Joyce O'Shaughnessy, MD - Harnessing Immunotherapy for Early Breast Cancer Management: Neoadjuvant Updates in HR-Positive, HER2-Negative Disease
|
Sep 20, 2024 |
|
Ahmad Tarhini, MD, PhD - Adjuvant Approaches in High-Risk, Resectable Melanoma: A Practical Guide to Improving Outcomes With Immunotherapy-Based Regimens
|
Sep 19, 2024 |
|
David M. Miller, MD, PhD / Todd Schlesinger, MD - A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies
|
Sep 13, 2024 |
|
Mark Awad, MD, PhD - Advancing the Therapeutic Landscape of SCLC with B7-H3–Targeted Antibody-Drug Conjugates: Insights and Future Directions
|
Sep 09, 2024 |
|
Leonard B. Bacharier, MD - Highlighting the Use of Biologics in Pediatric Patients: Case Scenarios to Elevate Asthma Treatment
|
Sep 09, 2024 |
|
Vasu Divi, MD, MS - Neoadjuvant Immunotherapy for CSCC: Practical Considerations for Resectability, Patient Selection, and Treatment Optimization
|
Sep 09, 2024 |
|
Vibeke Strand, MD / April W. Armstrong, MD, MPH - A New Take on TYK2 Inhibitors: Bridging Gaps in Psoriatic Arthritis Management With Novel Targeted Therapies
|
Sep 04, 2024 |
|
Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities
|
Aug 16, 2024 |
|
Aditya Bardia, MD - From Theory to Practice: Enhancing Antibody-Drug Conjugate Integration in HER2-Low Advanced Breast Cancer
|
Aug 09, 2024 |
|
Eileen Wang, MD, MPH - Breathing Life Into Type 2 Asthma: Advancing Clinical Remission With Biologics
|
Aug 05, 2024 |
|
Stephanie E. Combs, MD / Heather Wakelee, MD - A Growing Need for Targeted Approaches in Unresectable Stage III NSCLC: A Clinical Evaluation of Evolving Data in EGFR Mutation–Positive Disease
|
Aug 05, 2024 |
|
Rami Komrokji, MD - Navigating the First-Line Treatment Landscape of Anemia in Lower-Risk MDS: Translating the Latest Data to Practice
|
Aug 05, 2024 |
|
Chris Verslype, MD, PhD - Optimizing TKI Therapy for Individualized Advanced HCC Treatment: Taking a Real-World Perspective
|
Jul 12, 2024 |
|
Luis Paz-Ares, MD, PhD - Exploring the Potential of TROP2 ADCs for Advanced/Metastatic NSCLC: Implications for Practice
|
Jul 12, 2024 |
|
Ticiana Leal, MD - Squaring Off With Squamous NSCLC: The Latest Evidence and Guidance on Chemoimmunotherapy Options
|
Jul 04, 2024 |
|
Ghassan Abou-Alfa, MD, MBA - Getting On the Right Tract: Patient-Centered Strategies to Diagnose Biliary Tract Cancers
|
Jul 04, 2024 |
|
Jonathan Silverberg, MD, PhD, MPH - Taking a Hands-On Approach to the Management of Moderate to Severe Hand and Foot Atopic Dermatitis: Enhancing Patient Outcomes With Novel Systemic Therapies
|
Jul 04, 2024 |
|
Sagar Lonial, MD, FACP - Accelerating Targeted Degradation in Multiple Myeloma: The Role of CELMoDs in Overcoming IMiD Resistance in Earlier Lines of Therapy
|
Jul 04, 2024 |
|
Ben Carpenter, MD, PhD - Exploring Novel Therapeutic Frontiers in Transfusion-Dependent Beta Thalassemia: The Path to Transfusion Independence
|
Jun 25, 2024 |
|
Saad Z. Usmani, MD, MBA, FACP, FASCO - Making the Case for Triple Therapy in R/R Multiple Myeloma: Expert Guidance for Optimizing Anti-CD38 mAb Regimens
|
Jun 25, 2024 |
|
Michael Thorpy, MD - Narcolepsy and Cardiovascular Health: Real-World Strategies to Enhance Long-Term Patient Outcomes
|
Jun 25, 2024 |
|
Josep M. Llovet, MD, PhD - Redefining How to Treat Intermediate-Stage HCC: Exploring TACE Plus Immunotherapy–Based Combination Therapy
|
Jun 18, 2024 |
|
Richard Bernstein, MD, PhD - Factoring a Balanced Efficacy and Safety Profile Into the Equation: Exploring FXIa Inhibitors in Stroke Prevention
|
Jun 18, 2024 |
|
Richard Kim, MD - Enhancing Treatment Sequencing to Extend Survival: Tailoring Later-Line Care to the Patient With Metastatic Colorectal Cancer
|
May 28, 2024 |
|
Joseph Domachowske, MD - From Guidelines to Practice: The Latest Strategies for RSV Prevention in Infants
|
May 15, 2024 |
|
Nick H. Kim, MD - Multimodal Management of Inoperable CTEPH: Evolving Therapeutic Strategies
|
May 15, 2024 |
|
Jyoti Mayadev, MD - From Routine Screening to Applying Clinical Advances in Locally Advanced Cervical Cancer: Evolving Care in High-Risk Populations
|
Apr 30, 2024 |
|
M. Scott Perry, MD - Easing the Diagnostic Journey for Both Children and Adults With Lennox-Gastaut Syndrome: Patient-Centered Strategies
|
Apr 05, 2024 |
|
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
|
Apr 05, 2024 |
|
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
|
Apr 05, 2024 |
|
Geoffrey Ku, MD, MBA - Conversations in Precision Oncology: Harnessing Testing to Drive Personalized Treatment in HER2-Positive Advanced Gastric Cancer
|
Apr 05, 2024 |
|
Martin C. Mahoney, MD, PhD - Reducing the Burden of HPV-Related Cancers: Strategies for Improving HPV Vaccine Uptake in Males
|
Mar 29, 2024 |
|
Iacopo Olivotto, MD - A New Chapter in Hypertrophic Cardiomyopathy Management: Updates From the European Society of Cardiology (ESC) 2023 Guidelines and New Treatment Options
|
Mar 25, 2024 |
|
Laura Spring, MD - The Patient-Clinician Alliance to Enhance Care for Patients With Metastatic Breast Cancer on Antibody-Drug Conjugates
|
Mar 25, 2024 |